Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03244709
Recruitment Status : Unknown
Verified August 2017 by Fabrizio Cantini, Hospital of Prato.
Recruitment status was:  Recruiting
First Posted : August 9, 2017
Last Update Posted : August 10, 2017
Information provided by (Responsible Party):
Fabrizio Cantini, Hospital of Prato

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 31, 2017
Estimated Study Completion Date : December 31, 2017
Publications of Results:
Other Publications: